Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.

Dargaville P. A., Kamlin C. O. F., Orsini F., Wang X., De Paoli A. G., Kanmaz Kutman H. G., ...Daha Fazla

JAMA, cilt.326, ss.2478-2487, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 326
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1001/jama.2021.21892
  • Dergi Adı: JAMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Abstracts in Social Gerontology, AgeLine, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Food Science & Technology Abstracts, Gender Studies Database, Index Islamicus, International Pharmaceutical Abstracts, MEDLINE, MLA - Modern Language Association Database, Psycinfo, Public Affairs Index, Veterinary Science Database, DIALNET
  • Sayfa Sayıları: ss.2478-2487
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

IMPORTANCE The benefits of surfactant administration via a thin catheter (minimally invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome are uncertain.